Congressional Research Service Issues Report to Congress on Pending Synthetic Drug Legislation

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Congressional Research Service Issues Report to Congress on Pending Synthetic Drug Legislation

Staff Writers

November 9, 2011 at 19:00:00 ET

A report by the Congressional Research Service summarizes issues relating to recent legislative proposals that would amend the Controlled Substances Act to control more expeditiously synthetic drugs of abuse. The Oct. 28, 2011, report to Congress, "Synthetic Drugs: Overview and Issues for Congress," CRS R42066, discusses so-called designer drugs, bath salts, and other forms of non... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Congressional Research Service Issues Report to Congress on Pending Synthetic Drug Legislation

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT